Suppr超能文献

甲状腺“微粒体”抗原是促甲状腺激素受体上的一个表位。

The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.

作者信息

Islam N, Tuppal R, Hawe B S, Briones-Urbina R, Farid N R

出版信息

J Cell Biochem. 1986;31(2):107-20. doi: 10.1002/jcb.240310204.

Abstract

Antimicrosomal antibodies are present in the sera of most patients with autoimmune thyroiditis, and Graves' disease. It has, in general, been difficult to separate antimicrosomal activity from that directed against the thyrotropin (TSH) receptor in Graves' IgG preparations. The "microsomal" antigen has been localized to the endoplasmic reticulum and microfollicular aspect of thyrocytes; its structure is however unknown. In an attempt to identify the thyroid microsomal antigen, we studied the interaction of Hashimoto's IgG with high microsomal antibody titre and negative for thyroglobulin with purified thyroid plasma and light microsomal membranes. We allowed Hashimoto's, Graves', and control IgGs to bind to protein blots of thyroid plasma membranes resolved on SDS-PAGE under non-reducing conditions. All seven Hashimoto's IgG at a concentration of 2 mg/ml interacted with an M approximately 197,000 polypeptide corresponding to the TSH holoreceptor. By contrast to Graves' IgG (which were positive at 1 mg/ml), however, this binding was not blocked by pretreatment of the protein blots with TSH. Normal IgGs showed no binding at concentrations of up to 2 mg/ml. Both Hashimoto's and Graves' IgG interacted with TSH-affinity column-purified receptor preparations. Two of the Hashimoto's IgGs induced adenylate cyclase activation in thyroid plasma membranes, three inhibited TSH-stimulated enzyme activation, and two were without effect. Two classes of autoantibodies, other than TSH receptor directed, were encountered; one class raised to antigens common to all seven patients and another class unique to individual patients, eg, Mr 210,000 and Mr 20,000 polypeptides. We propose that the TSH receptor has multiple epitopes (functional domains), and the one to which antimicrosomal antibody bind is likely to be spatially separated from that with which Graves' IgG and TSH interact. Differences in affinity or number of sites allows for the demonstration of Graves' IgG against a background of antimicrosomal antibody.

摘要

抗微粒体抗体存在于大多数自身免疫性甲状腺炎和格雷夫斯病患者的血清中。一般来说,在格雷夫斯病的IgG制剂中,很难将抗微粒体活性与针对促甲状腺激素(TSH)受体的活性区分开来。“微粒体”抗原已定位到甲状腺细胞的内质网和微滤泡部分;然而,其结构尚不清楚。为了鉴定甲状腺微粒体抗原,我们研究了桥本氏病IgG(甲状腺微粒体抗体滴度高且甲状腺球蛋白阴性)与纯化的甲状腺质膜和轻微粒体膜的相互作用。我们让桥本氏病、格雷夫斯病和对照IgG在非还原条件下与经SDS-PAGE分离的甲状腺质膜蛋白印迹结合。所有七种浓度为2mg/ml的桥本氏病IgG都与一条分子量约为197,000的多肽相互作用,该多肽对应于TSH全受体。然而,与格雷夫斯病IgG(在1mg/ml时呈阳性)不同的是,这种结合不会被用TSH预处理蛋白印迹所阻断。正常IgG在浓度高达2mg/ml时未显示结合。桥本氏病和格雷夫斯病IgG都与TSH亲和柱纯化的受体制剂相互作用。两种桥本氏病IgG可诱导甲状腺质膜中的腺苷酸环化酶激活,三种可抑制TSH刺激的酶激活,两种则无作用。除了针对TSH受体的自身抗体外,还发现了两类自身抗体;一类针对所有七名患者共有的抗原,另一类是个别患者特有的,例如分子量为210,000和20,000的多肽。我们提出TSH受体有多个表位(功能域),抗微粒体抗体结合的表位可能在空间上与格雷夫斯病IgG和TSH相互作用的表位分开。亲和力或位点数量的差异使得在抗微粒体抗体背景下能够证明格雷夫斯病IgG的存在。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验